MMP2 and breast carcinoma: In gain of function studies, we find that PIAS1 acts in a SUMO E3 ligase-dependent manner to suppress the ability of TGFβ to promote activation of the matrix metalloproteinase 2 (MMP2) and associated invasive behavior of breast cancer cells.